News
News Center
Set in stone! Beijing and Anhui Pilot Free Trade Zones: Supporting the Launch of Cutting-Edge Clinical Medical Research Projects in Areas Like Immune Cells and Stem Cells
来源：Website of the Central People's Government of the People's Republic of China
2020-09-22
The State Council's latest policy, "Notice from the State Council on Issuing the Overall Plan for the Beijing, Hunan, and Anhui Free Trade Pilot Zones and the Expansion Area Plan for the Zhejiang Free Trade Pilot Zone," No. Guofa [2020] 10, was finalized on August 30, 2020, and officially released on September 21, 2020.
Here's the excerpt regarding cell therapy:
China (Beijing) Pilot Free Trade Zone Overall Plan: 15. Foster innovative development of a world-leading medical and healthcare industry. Streamline the approval process for domestic biopharmaceutical R&D entities engaging in international collaborative research and development. Expedite customs clearance for urgently needed medical devices, as well as R&D materials, reagents, and equipment. Accelerate the review and approval of medical devices that are clinically essential but currently lack approved counterparts in China, ensuring timely access to these critical tools. Additionally, advance cross-border remote medical initiatives and other clinical research projects. Medical institutions within the region can, based on their own technical capabilities, carry out cutting-edge clinical research projects involving stem cells in accordance with relevant regulations. Explore piloting decentralized clinical trials (DCTs). Support the establishment of the Beijing Service Station for Medical Device Innovation and the Human Genetic Resources Service Station to accelerate the pace of pharmaceutical industry transformation.
China (Anhui) Pilot Free Trade Zone Overall Plan: 11. Building a Hub for Science and Technology Innovation. We will strengthen the systems and mechanisms that support basic research and original innovation, helping to establish the framework of the Hefei Comprehensive National Science Center. We’ll actively strive to create a national laboratory and explore innovative models for its construction and operation. Additionally, we’ll provide support for preliminary research on major scientific infrastructure projects such as the Hefei Advanced Light Source, the Three-Dimensional Atmospheric Environment Detection System, and the Strong Light-Magnetic Facility. We’ll also facilitate the establishment of an Environmental Science R&D Platform and a Comprehensive Research Base for Future Technologies. Furthermore, we’ll back efforts to enhance and expand the capabilities of existing large-scale scientific facilities, including the All-Superconducting Tokamak, the Synchrotron Radiation Source, and the Steady-State High-Field Magnetic Facility, while accelerating the construction of integrated research facilities for key fusion reactor systems. Finally, we’ll support the establishment of the Energy Research Institute and the Artificial Intelligence Research Institute, and plan the creation of a Greater Health Research Institute. We’ll also bolster the development of the National Research Center for Microscale Material Sciences, the Hefei Advanced Computing Center, and several national key laboratories. Together, these initiatives will ensure the high-quality construction of a robust network of provincial-level laboratories and technology innovation centers. Support the implementation of cutting-edge clinical medical technology research projects, such as immune cell and stem cell therapies. Promote the opening of major national scientific research infrastructures and large-scale research instruments to entrepreneurs in relevant industries.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy